Madurella mycetomatis is highly susceptible to ravuconazole.

• Principais autores: Sarah Abdalla Ahmed (Autor), Wendy Kloezen (Autor), Frederick Duncanson (Autor), Ed E Zijlstra (Autor), G Sybren de Hoog (Autor), Ahmed H Fahal (Autor), Wendy W J van de Sande (Autor)
• Formato: Livro
• Publicado em: Public Library of Science (PLoS), 2014-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The current treatment of eumycetoma utilizing ketoconazole is unsatisfactory because of high recurrence rates, which often leads to complications and unnecessary amputations, and its comparatively high cost in endemic areas. Hence, an effective and affordable drug is required to improve therapeutic...